Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-26 @ 2:21 AM
Study NCT ID:
NCT05465902
Status:
WITHDRAWN
Last Update Posted:
2025-03-28
First Post:
2022-07-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster
Sponsor:
WestVac Biopharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-18
First Submit QC Date:
None
Study First Post Date:
2022-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-24
Last Update Post Date:
2025-03-28
Last Update Post Date Type:
ACTUAL